PRO DEX INC - 10-K Filing Summary
Business Context and Reporting Period
Company: PRO DEX INC (PDEX)
Filing Type: Form 10-K (Annual Report)
Fiscal Year Ended: June 30, 2025
Business Overview: Pro-Dex specializes in the design, development, and manufacture of autoclavable, battery-powered, and electric multi-function surgical drivers and shavers for orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also provides repair services and manufactures rotary air motors. Operations are conducted as a single segment with facilities in Irvine and Tustin, California.
Key Financial Metrics
| Metric (in thousands) | Fiscal 2025 | Fiscal 2024 |
|---|---|---|
| Net Sales | $66,593 | $53,844 |
| Gross Profit | $19,510 | $14,551 |
| Gross Margin | 29% | 27% |
| Operating Income | $10,689 | $7,173 |
| Net Income | $8,978 | $2,127 |
| Diluted EPS | $2.67 | $0.60 |
| Cash & Equivalents | $419 | $2,631 |
| Working Capital | $32,666 | $23,719 |
| Total Debt (Notes Payable) | $15,431 | $11,956 |
| Backlog | $50,400 | $19,800 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 24% ($12.7 million) driven primarily by a 29% increase in medical device sales ($10.8 million) and a 13% increase in repair revenue ($2.1 million). The largest customer accounted for 75% of total sales in 2025, up from 71% in 2024.
- Profitability: Net income surged 322% to $8.98 million. This was significantly aided by a $1.52 million unrealized gain on marketable equity investments and a $595,000 realized gain on the sale of investments, compared to a $4.1 million unrealized loss in the prior year.
- Operating Cash Flow: Operating cash flow turned negative at $(1.68) million, a reversal from the $6.22 million positive flow in 2024. This was due to a $6.9 million increase in inventory to support backlog, a $2.5 million increase in accounts receivable, and $1.5 million in income tax payments.
- Debt & Liquidity: Total notes payable increased to $15.4 million. The company increased its revolving credit line availability to $11 million. Cash on hand decreased to $419,000.
Guidance, Outlook, and Risks
- Outlook: Management anticipates sufficient funds to meet requirements for the next 12 months based on working capital and anticipated cash flows. The company expects to deliver substantially all of its $50.4 million backlog during fiscal 2026.
- Customer Concentration: A critical risk is the reliance on a single customer for 75% of sales. While supply agreements extend through calendar 2025, there is no assurance of extension beyond that date.
- Supply Chain & Tariffs: The company faces risks from supplier lead times and potential tariff charges on imported raw materials, which may increase costs and reduce margins if not passed to customers.
- Internal Controls: The company previously identified material weaknesses in internal controls (inventory accounting and investment valuation) in 2023 and 2024. Management concluded that internal controls were effective as of June 30, 2025, following remediation efforts.
- Investment Volatility: A significant portion of net income is derived from the company's investment portfolio ($6.9 million fair value), which is subject to market volatility and unrealized gains/losses.
Investor Verification Checklist
- Customer Retention: Verify the status of the supply agreement with the top customer (75% of revenue) beyond calendar 2025.
- Cash Flow Sustainability: Assess the ability to generate positive operating cash flow given the significant inventory build-up and low cash balance ($419k).
- Investment Realization: Determine the liquidity of the $6.9 million investment portfolio and the likelihood of realizing the $3.3 million in unrealized gains.
- Debt Covenants: Review the specific financial covenants in the credit agreements with Minnesota Bank & Trust (now UMB Bank) to ensure compliance given the negative operating cash flow.
- Tariff Impact: Monitor the ability to pass through increased supplier costs and tariff charges to customers without losing market share.